Original Article

You have full text access to this OnlineOpen article

Evolving trends in multiple-antibiotic–resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns

  1. Nina Singh MD*,
  2. Timothy Gayowski,
  3. John D. Rihs,
  4. Marilyn M. Wagener,
  5. Ignazio R. Marino

Article first published online: 30 DEC 2003

DOI: 10.1053/jlts.2001.20769

Issue

Liver Transplantation

Liver Transplantation

Volume 7, Issue 1, pages 22–26, January 2001

Additional Information

How to Cite

Singh, N., Gayowski, T., Rihs, J. D., Wagener, M. M. and Marino, I. R. (2001), Evolving trends in multiple-antibiotic–resistant bacteria in liver transplant recipients: A longitudinal study of antimicrobial susceptibility patterns. Liver Transpl, 7: 22–26. doi: 10.1053/jlts.2001.20769

Author Information

  1. From the Infectious Disease Section, Veterans Affairs Medical Center, Pittsburgh, PA.

*Infectious Disease Section, VA Medical Center, University Drive C, Pittsburgh, PA 15240. Telephone: 412-688-6179; FAX: 412-688-6950

Publication History

  1. Issue published online: 30 DEC 2003
  2. Article first published online: 30 DEC 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (178K)

References

  • 1
    Chien JW, Kucia ML, Salata RA. Use of linezolid, an oxazolidinone, in serious vancomycin-resistant enterococcal infections [abstract 605]. Presented at the 36th Annual Meeting of the Infectious Diseases Society of America, Denver, CO, November 12–15, 1998.
  • 2
    Quale J, Landman D, Saurina G, Atwood E, DiTore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996; 23:1020–1025. MEDLINE
  • 3
    Vincent JE, Bojaro DJ, Suter PM, Bruining HA, White J, Nicholas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274:639–644. MEDLINE
  • 4
    Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin Infect Dis 1999; 29:245–252. MEDLINE
  • 5
    Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med 1996; 100(suppl):3S–12S. MEDLINE
  • 6
    Wiedman B. Epidemiology, control and treatment of multiresistant gram-negative rods. Drugs 1996; 52:95–102. MEDLINE
  • 7
    Paterson DL, Yu VL. Extended-spectrum β-lactamase: A call for improved detection and control. Clin Infect Dis 2000; 29:1419–1422.
  • 8
    Linden PK, Pasculle AW, Manez Retal. Differences in outcome for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium. Clin Infect Dis 1996; 22:663–670. MEDLINE
  • 9
    Papanicolaou GA, Myers BR, Meyers J, Mendelson MH, Lou W, Emre S, et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality. Clin Infect Dis 1996; 23:760–766. MEDLINE
  • 10
    Singh N, Yu VL. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients. Is emergence of resistance imminent? Dig Dis Sci 1998; 43:1190–1192. MEDLINE
  • 11
    Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Mariono IR. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998; 65:1169–1172. MEDLINE
  • 12
    Singh N, Chang FY, Gayowski T, Wagener MM, Marino IR. Fever in liver transplant recipients in the 1990s: Changing spectrum of etiologic agents. Clin Infect Dis 1998; 26:59–65. MEDLINE
  • 13
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions of nosocomial infections. Am J Infect Control 1988; 16:128–140. MEDLINE
  • 14
    Muder RR, Brennen C, Drenning SD, Stout JE, Wagener MM. Multiply antibiotic-resistant gram-negative bacilli in a long-term care facility: A case-control study of patient risk factors and prior antibiotic use. Infect Control Hosp Epidemiol 1997; 18:809–813. MEDLINE
  • 15
    Paterson DL, Muder RR, Squier C, Teramana CE, Rihs BL, Rihs JD, et al. Outbreak of infection with E coli harboring extended-spectrum beta-lactamase (ESBL) in a liver transplant unit: Could norfloxacin administration to carriers contribute to control? [abstract K-95] 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 1998.
  • 16
    Paterson DL, Ko W, Von Gottberg A, Klugman K, Mohapatra S, Trenholme G, et al. Epidemiology of bacteremia due to multiply resistant extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae in transplant unit patients [abstract 1426]. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26–29, 1999.
  • 17
    NCCLS: Performance Standards for Antimicrobial Susceptibility Testing. Ninth Informational Supplement M100-59, Vol. 19, No. 1. 199.
  • 18
    Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180:384–390. MEDLINE
  • 19
    Singh N, Paterson D, Chang FY, Gayowski T, Squier C, Wagener MM, et al. Methicillin-resistant Staphylococcus aureus: The other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000; 30:322–327. MEDLINE
Get PDF (178K)